These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 9708450
21. Maintenance therapy in childhood acute myeloid leukemia. Perel Y, Auvrignon A, Leblanc T, Michel G, Vannier JP, Dalle JH, Gandemer V, Schmitt C, Mèchinaud F, Lamagnere JP, Piguet Ch, Couillaud G, Pautard B, Baruchel A, Leverger G, Group LAME, French Society of Pediatric Hematology and Immunology. Ann Hematol; 2004; 83 Suppl 1():S116-9. PubMed ID: 15124700 [Abstract] [Full Text] [Related]
22. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D. J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120 [Abstract] [Full Text] [Related]
23. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission. Cortes JE, Kantarjian HM, O'Brien S, Giles F, Keating MJ, Freireich EJ, Estey EH. Cancer; 1999 Apr 01; 85(7):1506-13. PubMed ID: 10193940 [Abstract] [Full Text] [Related]
24. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S. Bone Marrow Transplant; 1999 Sep 01; 24(5):467-72. PubMed ID: 10482929 [Abstract] [Full Text] [Related]
25. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). Sperr WR, Piribauer M, Wimazal F, Fonatsch C, Thalhammer-Scherrer R, Schwarzinger I, Geissler K, Knöbl P, Jäger U, Lechner K, Valent P. Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3965-71. PubMed ID: 15217926 [Abstract] [Full Text] [Related]
32. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, Tsuchida M, Tokyo Children's Cancer Study Group. Pediatr Blood Cancer; 2007 Aug 15; 49(2):127-32. PubMed ID: 16807916 [Abstract] [Full Text] [Related]
33. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R, Guardia R, Altés A, Sureda A, Brunet S, Sierra J. Haematologica; 1999 Mar 15; 84(3):226-30. PubMed ID: 10189387 [Abstract] [Full Text] [Related]
34. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. Visani G, Lemoli RM, Isidori A, Piccaluga PP, Martinelli G, Malagola M, Gugliotta L, Bonini A, Bonifazi F, Motta MR, Rizzi S, Castellani S, Tura S. Bone Marrow Transplant; 2001 Apr 15; 27(8):829-35. PubMed ID: 11477440 [Abstract] [Full Text] [Related]
35. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia. Lee JH, Choi SJ, Lee JH, Park JH, Kim H, Joo YD, Lee WS, Zang DY, Kim HJ, Lee KH, Cooperative Study Group A for Hematology. Ann Hematol; 2006 Jun 15; 85(6):357-65. PubMed ID: 16575580 [Abstract] [Full Text] [Related]
36. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Martino R, Bellido M, Brunet S, Altés A, Sureda A, Guárdia R, Aventín A, Nomdedéu JF, Domingo-Albós A, Sierra J. Haematologica; 1999 Jun 15; 84(6):505-10. PubMed ID: 10366793 [Abstract] [Full Text] [Related]
38. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia. Roberts MM, Juttner CA, Blunden RW, Horvath N, To LB, Ho JQ, Dart GW, Kimber RJ. Med J Aust; 1988 Feb 15; 148(4):181-3. PubMed ID: 3340044 [Abstract] [Full Text] [Related]
40. Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse. Emura I, Chou T, Ishiguro T, Kakihara T, Naito M, Yoshizawa H, Arakawa M. Pathol Int; 1998 Jul 15; 48(7):526-35. PubMed ID: 9701015 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]